{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:26:32Z","timestamp":1648761992972},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.ejphar.2004.06.066","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T15:25:56Z","timestamp":1091719556000},"page":"327-334","source":"Crossref","is-referenced-by-count":7,"title":["Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia"],"prefix":"10.1016","volume":"497","author":[{"given":"Akiyoshi","family":"Ohtake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikashi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Sasamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.06.066_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/bmj.308.6934.929","article-title":"New words for old: lower urinary tract symptoms for prostatism","volume":"308","author":"Abrams","year":"1994","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2004.06.066_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1464-410X.1997.00380.x","article-title":"A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective \u03b11A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia)","volume":"80","author":"Abrams","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(91)90779-P","article-title":"5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug","volume":"205","author":"Borbe","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib4","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(17)35874-3","article-title":"Specificity of the American Urological Association Voiding Symptom Index: comparison of unselected and selected samples of both sexes","volume":"150","author":"Chai","year":"1993","journal-title":"J. Urol."},{"issue":"3 Suppl 1","key":"10.1016\/j.ejphar.2004.06.066_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0090-4295(03)00589-2","article-title":"Lower urinary tract symptoms\/benign prostatic hyperplasia: fast control of the patient's quality of life","volume":"62","author":"Djavan","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2004.06.066_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1113\/jphysiol.1907.sp001198","article-title":"The innervation of the bladder and urethra","volume":"35","author":"Elliot","year":"1907","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0922-4106(95)90195-7","article-title":"Use of recombinant \u03b11-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy","volume":"288","author":"Foglar","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib8","first-page":"703","article-title":"The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype","volume":"45","author":"Forray","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1124\/jpet.300.2.478","article-title":"Preclinical pharmacology of fiduxosin, a novel \u03b11-adrenoceptor antagonist with uroselective properties","volume":"300","author":"Hancock","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.06.066_bib10","first-page":"211","article-title":"Effect of tamsulosin on phenylephrine-induced intraurethral pressure elevation in conscious dogs: the relationship between pharmacokinetics and pharmacodynamics","volume":"165","author":"Hatanaka","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib11","first-page":"267","article-title":"International Union of Pharmacology X. Recommendation for nomenclature of \u03b11-adrenoceptors: consensus update","volume":"47","author":"Hieble","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2004.06.066_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005344-199102000-00006","article-title":"Naftopidil, a new \u03b1-adrenoceptor blocking agent with calcium antagonistic properties: characterization of Ca2+ antagonistic effects","volume":"17","author":"Himmel","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0160-5402(89)90039-9","article-title":"Functional evaluation of sympathetically mediated responses in in vivo lower urinary tract of dogs","volume":"22","author":"Imagawa","year":"1989","journal-title":"J. Pharmacol. Methods"},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2004.06.066_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1464-410X.2000.00060.x","article-title":"Current view and status of the treatment of lower urinary tract symptoms and neurogenic lower urinary tract dysfunction","volume":"85","author":"Kakizaki","year":"2000","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2004.06.066_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1464-410X.1997.00411.x","article-title":"Clinical comparison of selective and non-selective \u03b11A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses","volume":"80","author":"Lee","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1476-5381.1993.tb13762.x","article-title":"Alfuzosin, a selective \u03b11-adrenoceptor antagonist in the lower urinary tract","volume":"109","author":"Lefevre-Borg","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib17","first-page":"1272","article-title":"Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15\/2739 (SB216469): role of the alpha-1L adrenoceptor in tissue selectivity: Part I","volume":"281","author":"Leonardi","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.06.066_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1476-5381.1995.tb15001.x","article-title":"Noradrenaline contraction of human prostate mediated by \u03b11A (\u03b11C) adrenoceptor subtype","volume":"115","author":"Marshall","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00169183","article-title":"Classification of \u03b11-adrenoceptor subtypes","volume":"352","author":"Michel","year":"1995","journal-title":"Naunyn-Schmiedebergs Arch. Pharmakol."},{"issue":"Suppl 4A","key":"10.1016\/j.ejphar.2004.06.066_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0090-4295(98)00054-5","article-title":"Overview of \u03b1-blocker therapy for benign prostatic hyperplasia","volume":"51","author":"Narayan","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2004.06.066_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.ju.0000076140.68657.fd","article-title":"Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia","volume":"170","author":"Narayan","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1996.tb15742.x","article-title":"Quantification and distribution of \u03b11-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue","volume":"119","author":"Nasu","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/sj.bjp.0701731","article-title":"Quantification and distribution of \u03b11-adrenoceptor subtype mRNAs in human proximal urethra","volume":"123","author":"Nasu","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib24","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0024-3205(98)00495-0","article-title":"Ex vivo occupancy by tamsulosin of \u03b11-adrenoceptors in rat tissues in relation to the plasma concentration","volume":"63","author":"Ohkura","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2004.06.066_bib25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0302-2838(02)00438-4","article-title":"The relationships among filling, voiding subscores from international prostate symptom score and quality of life in Japanese elderly men and women","volume":"42","author":"Okamura","year":"2002","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-5347(17)35544-1","article-title":"Identification, quantification, and localization of mRNA for three distinct alpha-1-adrenergic receptor subtypes in human prostate","volume":"150","author":"Price","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1476-5381.1991.tb12290.x","article-title":"The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors","volume":"102","author":"Ramage","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib28","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.100.23.2336","article-title":"Subtype specific regulation of human vascular \u03b11-adrenergic receptors by vessel bed and age","volume":"100","author":"Rudner","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2004.06.066_bib29","first-page":"697","article-title":"Pharmacological effect of tamsulosin in relation to dog plasma and tissue concentrations: prostatic and urethral retention possibly contributes to uroselectivity of tamsulosin","volume":"296","author":"Sato","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.06.066_bib30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0090-4295(03)00037-2","article-title":"American urological association symptom index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life","volume":"61","author":"Scarpero","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2004.06.066_bib31","first-page":"265A","article-title":"The relationship between histological and clinical response to alpha blockade in men with symptomatic BPH","volume":"145","author":"Shapiro","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0094-0143(21)00664-9","article-title":"Pathophysiology of clinical benign prostatic hyperplasia","volume":"22","author":"Shapiro","year":"1995","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.ejphar.2004.06.066_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1474-8673.1992.tb00340.x","article-title":"Effect of optimal isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs","volume":"12","author":"Shibasaki","year":"1992","journal-title":"J. Auton. Pharm."},{"key":"10.1016\/j.ejphar.2004.06.066_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1254\/jjp.79.447","article-title":"Naftopidil, a novel \u03b11-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human \u03b11-adrenoceptors","volume":"79","author":"Takei","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1248\/yakushi1947.115.10_773","article-title":"Discovery and development of tamsulosin hydrochloride, a new \u03b11-adrenoceptor antagonist","volume":"115","author":"Takenaka","year":"1995","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejphar.2004.06.066_bib36","first-page":"1","article-title":"Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes","volume":"280","author":"Taguchi","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.06.066_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(93)90527-O","article-title":"Characterization of \u03b11-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man","volume":"249","author":"Testa","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1440-1681.1994.tb02534.x","article-title":"Comparative study on \u03b11-adrenoceptor antagonist binding in human prostate and aorta","volume":"21","author":"Yamada","year":"1994","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2004.06.066_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.300.2.495","article-title":"Modeling of relationship between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with \u03b11-adrenoceptor antagonists","volume":"300","author":"Witte","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904007071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904007071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T21:03:29Z","timestamp":1624568609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904007071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0014299904007071"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.06.066","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}